Craft

Autobahn Therapeutics

Total Funding

$76 M

Autobahn Therapeutics Summary

Company Summary

Overview
Autobahn Therapeutics is a company focused on improving life health for people affected by CNS disorders. The company leverages a deep understanding of validated human biology coupled with its brain-targeting chemistry platform to develop thyroid hormone receptor beta agonist therapies that harness the regenerative power of the human body.
Type
Private
Status
Active
Founded
2017
HQ
San Diego, CA, US | view all locations
Website
https://autobahntx.com/
Cybersecurity rating
Sectors

Key People

  • Brian Stearns

    Brian Stearns, Chief Scientific Officer

    • John Borkholder

      John Borkholder, General Counsel and Senior Vice President, Administration

      • Deidre MacKenna

        Deidre MacKenna, Vice President, Biology

        • Kristina Burow

          Kristina Burow, Director

          LocationsView all

          1 location detected

          • San Diego, CA HQ

            United States

            9880 Campus Point Dr

          Footer menu